Patent Application
20090258946
The Present Invention relates to products manufactured by combining chemical substances that create an electrostatic field capable of attracting or repelling airborne contaminants with products otherwise developed for various common uses in connection with the human body. One such product is a family of nasal sprays currently used for other purposes combined with cationic agents to enable restricting the flow of airborne contaminants into the nasal passages. This reduces the inflow of airborne contaminants to the nasal passages by capturing the contaminants and keeping them from entering the body. A second product is cosmetic makeup applied to the face, such as facial makeup, clown or theatrical makeup, or camouflage face paint. Such a product captures airborne contaminants, thereby preventing from entering the wearer's nasal passages.
In the Present Invention, chemical substances that create an electrostatic charged can be paired with products for different uses to create new products with properties that enhance the uses and effectiveness of the earlier products. Such products with desired electrostatic properties can be broadly categorized as:
These multipurpose products can be formulated in the medium that is commonly associated with each of the paired products, or in any manner, such as cream, lotion, towelette or wipe, makeup or paint, spray, wash, gel, tissue, cotton swab, foam swab, mask, etc.
Prior art products were limited to capturing airborne particulates that were essentially responsible for hay fever and the like, as well as killing harmful microorganisms or preventing them from entering the nose. It did not combine the aforementioned use with other, unrelated, products applied to the face, or the nasal region.
Allergic rhinitis, the medical name for hay fever, is caused by body's reaction to tiny substances in the air called allergens. Allergens are generally harmless, and we breathe them in and out all the time. If a person suffers from allergies, the body believes these allergens are attacking the system. The body fights back by producing chemicals called histamines, which cause nasal passages to become irritated or inflamed. Allergic rhinitis generally does not create serious health problems, but it can make life very uncomfortable for those who have it.
Some of the most common symptoms of allergic rhinitis are congestion, itchy and/or runny nose, sneezing, and postnasal drip. These symptoms are body's natural response to the seasonal allergens or environmental irritants inhaled. Furthermore, rhinitis occurs during specific seasons, or continues throughout the year. How long the allergy symptoms continue may depend on type of rhinitis. Sinusitis often presents with similar symptoms.
Allergy and sinusitis sufferers may obtain relief using nasal sprays and they consist of the following five categories:
Other products are applied to the face, such as nasal strips, fragrances, sunscreens, and cosmetics such as camouflage paint and facial makeup. These products have ordinary uses. They are applied to the faces of non-allergic persons as well as to those of allergy sufferers. If airborne particulate allergens can be prevented from entering the nose and contacting the nasal mucosa, allergic rhinitis could be greatly alleviated.
The Present Invention is a group of new products designed to ameliorate symptoms of sinusitis and allergic rhinitis by combining certain chemical substances with existing products, thereby producing a synergistic effect. The chemical substances create an electrostatically charged field around the nose and prevent allergens or pollutants from entering the nostrils to cause a reaction, illness, or discomfort for the user. Therefore, the Present Invention comprises products, which are applied to the face, and therefore around the nose and nasal passages, as well as those applied directly into the nose. These products include but are not limited to nasal sprays, sunscreens, nasal strips, swabs (medicated and non-medicated), tissues, towelettes, cosmetics, and fragrances. Common nasal sprays often comprise saline solutions. Cosmetics comprise camouflage paint or facial makeup. These are but examples of the type of products with which these chemical substances may be effectively combined. The principle function of the Present Invention is to prevent harmful airborne particulates from entering the nose when either sprayed into the nose or applied to the face.
The multi-purpose products of the Present Invention possess the following properties:
ASTELIN® is the only prescription antihistamine spray approved to treat nasal symptoms triggered by both seasonal allergens and environmental irritants. Its active ingredient is Azelastine HCL. Inactive ingredients include:
An example of camouflage paint would include:
Note that all of the nasal sprays listed above contain Benzalkonium Chloride, and neither of the camouflage paints contains that substance. For both products, Benzalkonium Chloride are either introduced or increased in amount to maximize the biocide effect, increase cationic skin adherence properties, and provide greater skin penetration to enhance the active ingredients. Similarly, Lysine HCL is introduced into the nasal sprays to act as a biocide and to act as a mucous membrane conditioner. Furthermore, special isotonic ingredients with moisturizing effects should be introduced. These include seed weed extracts and algae extracts.
Primarily, effective amounts of cationic agents are introduced to enhance the benefits of using the product. These cationic agents include without limitation:
A number of effective nasal sprays have been developed by the Inventor to clear blocked sinuses. One such spray comprised 1% by weight of Polyquaternium-10 in aqueous solution as the active ingredient. Another comprised 0.75% by weight of Polyquaternium-6 in aqueous solution, which was found to be more effective.
The existing products often, but not always, comprise preservatives and other biocidic substances. The final products should contain these materials. Examples are anti-microbal and biopharg agents. Typical of these are Benzalkonium Chloride and Lysine HCL, respectively.
In addition, the aforementioned chemical substances may be introduced to wipes, towelettes, and wet tissues, all to be used for application to the face.
In summary, products such as saline solutions, fragrances, sunscreens, moisturizers, cosmetics, camouflage paint, and surgical masks, in the form of a cream, lotion, gel, liquid, spray, mist, wash, swab, strip, wipe, towelette, tissue, stick, or any other method can be integrated appropriately with electrostatic charge adequate for the intended uses.
The Present Application is the non-provisional counterpart of U.S. Provisional Patent Application Ser. No. 61/078,472 (hereinafter the '472 Application) filed on Jul. 7, 2008. The Present Application claims the benefit of and priority to the 472′ Application which is incorporated by reference in its entirety herein.The '472 Application discloses identical material to my prior U.S. Provisional Patent Application Ser. No. 60/598,462 (hereinafter the '462 Application) filed on Aug. 3, 2004 (now expired) entitled: “ELECTROSTATICALLY CHARGED NASAL APPLICATION MULTIPURPOSE PRODUCTS AND METHOD.” No new matter was added to the '462 Application to create the '472 Application. Said '462 Application is incorporated by reference in its entirety herein.The Present Application is additionally related to my U.S. Pat. No. 5,468,488, entitled “ELECTROSTATICALLY CHARGED NASAL APPLICATION PRODUCT AND METHOD” issued on Nov. 21, 1995. This patent is incorporated by reference in its entirety herein.The Present Application is further related to my U.S. Pat. No. 5,674,481, entitled “ELECTROSTATICALLY CHARGED NASAL APPLICATION PRODUCT” issued on Oct. 7, 1997. This patent is incorporated by reference in its entirety herein.The Present Application is moreover related to my U.S. Pat. No. 6,844,005 entitled “ELECTROSTATICALLY CHARGED NASAL APPLICATION PRODUCT WITH INCREASED STRENGTH” issued on Jan. 18, 2005. This patent is incorporated by reference in its entirety herein.
| Number | Date | Country | |
|---|---|---|---|
| 61078472 | Jul 2008 | US |
